Price target
466.230.00 0.00%
The 27 analysts offering 1 year price forecasts for VRTX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 33 analysts giving stock ratings to VRTX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
VRTX EPS for the last quarter is 4.76 USD despite the estimation of 4.07 USD. In the next quarter EPS is expected to reach 4.17 USD. Track more of Vertex Pharmaceuticals Incorporated financials and stay on top of what is up with the company.
In the next quarter Vertex Pharmaceuticals Incorporated revenue is expected to reach 2.66 B USD. Check out Vertex Pharmaceuticals Incorporated revenue and earnings and make informed decisions.
According to analysts, VRTX price target is 466.23 USD with a max estimate of 577.00 USD and a min estimate of 325.00 USD. Check if this forecast comes true in a year, meanwhile watch Vertex Pharmaceuticals Incorporated stock price chart and keep track of the current situation with VRTX news and stock market news.
We've gathered opinions of 33 analysts rating VRTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.